Reduced Chemotherapy Protocol Achieves High Survival in Pediatric Unilateral Retinoblastoma Trial
A clinical trial evaluating reduced-intensity adjuvant chemotherapy and targeted delivery in pediatric unilateral retinoblastoma demonstrated a 98.7 percent three-year overall ...




















